Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: sites default files B Calingaert ICPEPoster pdf
Final FDA Guidance on Real-World Data and Real-World-Evidence for Drug and Biological Products Share on: October 10, 2023 In response to the 21st Century Cures Act, which aims to accelerate medical product development and innovation, the United States …
Alicia Gilsenan Pharmacoepidemiology and Risk Management Women's Health Respiratory Oncology Men's Health Infectious Disease Hematology Diabetes & Endocrine Disorders CNS/Neurology Cardiovascular Headquarters - Research Triangle Park, North Carolina, USA …
Kelly Hollis Surveys and Observational Studies Vaccines Oncology Gastroenterology Dermatology Headquarters - Research Triangle Park, North Carolina, USA MBA, Kenan Flagler Business School University of North Carolina at Chapel Hill, Chapel Hill, NC BA, …
Audra Gold Patient-Centered Outcomes Assessment Telecommuter - USA MSc, Global Health Georgetown University, Washington, DC BS, Psychology Florida Southern College, Lakeland, FL Measurement, Design, and Analysis for Health Outcomes Research Harvard T.H. …
Recent FDA Drug and Device Guidelines for Sharing Pre-Approval Information Share on: July 17, 2018 Communication of Pre-approval Information by Drug and Device Manufacturers to Payers in the US In the US, once a drug or medical device has been approved …
Key Themes and Insights From ASCO 2024: A Glimpse Into the Future of Oncology Share on: June 12, 2024 The ASCO 2024 conference was a hub of innovation and collaboration, bringing together healthcare providers, pharma, and patients to advance the field of …
RTI and Nested Knowledge Announce Collaboration to Enhance Life Science and Healthcare Research Share on: April 24, 2024 Strategic collaboration follows RTI’s equity investment in advanced tech-enabled research services RESEARCH TRIANGLE PARK, N.C. — RTI …
CHEERS 2022: A Conversation With Jo Mauskopf on Updated Standards for Health Economic Evaluation Reporting Share on: March 1, 2022 Guidance Expanded to Reflect Developments in Reporting Economic Evaluations of Health Interventions As part of …
ICER’s 2023 Value Assessment Framework Updates: How Might Changes Impact Pharmaceutical Companies? Share on: July 28, 2023 Article contributed by Naoko Ronquest (she/her), PhD, Executive Director, US HTA Strategy and Early Modeling and Kyle Paret , PhD, …